BIOS SEC filings, in plain English
Everything BioPlus Acquisition Corp. has filed with the SEC that we hold — 40 filings, newest first, 4 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
- What changed vs 2023-05-15trust $240.4M → $138.4M -42%shares 23.0M → 13.1M -43%
trust account, redeemable shares, combination deadline +12 moved · 2 with no prior record of ours
- Trust account
- $240.4M$138.4M
- Redeemable shares
- 23.0M13.1M
- Combination deadline
- 2023-12-07 · unchanged
- Going-concern doubt
- stated · unchanged
SpacBrain reads this as $101,939,256 left the trust between the two filings.
The clause …“194,386 408,461 Total Current Assets 196,840 548,763 Cash and investments held in Trust Account 138,433,205 237,775,823 TOTAL ASSETS $ 138,630,045 $ 238,324,586 LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND”…
SpacBrain reads this as 9,942,523 shares are no longer redeemable.
The clause …“authorized; 6,309,999 and 560,000 s hares issued and outstanding (excluding 13,057,477 and 23,000,000 shares subject to possible redemption) as of June 30, 2023 and December 31, 2022, respectively 631 56 Class B ordinary shares, $”…
The clause …“to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by December 7, 2023, the extended liquidation date, then the Company will cease all operations except for the purpose of liquidating. The”…
The clause …“well as the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: BioPlus Acquisition Corp. ('BIOS', a Cayman Islands exempted company) filed Amendment No. 2 to its Form S-4; the preliminary proxy statement/prospectus inside is dated August 1, 2023. No explanatory note names the change. It registers 46,146,918 shares of common stock and 11,780,000 warrants of BIOS after its domestication as a Delaware corporation, to be renamed AVERTIX MEDICAL, INC. BIOS will migrate to and domesticate as a Delaware corporation prior to the closing. Why it matters: The registered ceiling is 46,146,918 shares plus 11,780,000 warrants, the warrant leg being roughly 26% of the share leg and a separate claim on the equity. The Sponsor is a party to the business combination agreement but ONLY for two specified sections, which is a narrower role than a full party and means sponsor obligations are confined to those provisions — worth checking against the agreement rather than assumed to be broad. The target trades under a name it recently changed from Angel Medical Systems, Inc., so historical records may sit under the former name.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $40.0M · unchanged
- Outside date
- 2023-12-31 · unchanged
The clause …“Maximum Redemptions: The Business Combination Agreement includes an Available Minimum Cash Condition of $40,000,000. The minimum cash condition is determined based on the following: (i) the funds in the Trust Account, plus (ii) the”…
The clause …“BIOS or Avertix Medical if the Effective Time has not have occurred prior to December 31, 2023 (the “ Outside Date ”); provided , however , that the Business Combination Agreement may not be so terminated by or on behalf of any party”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: BioPlus Acquisition Corp. ('BIOS', a Cayman Islands exempted company) filed Amendment No. 1 to its Form S-4; the preliminary proxy statement/prospectus inside is dated June 29, 2023. No explanatory note names the change. It registers 46,146,918 shares of common stock and 11,780,000 warrants of BIOS after its domestication as a Delaware corporation, to be renamed Avertix Medical, Inc. BIOS will migrate to and domesticate as a Delaware corporation prior to the closing. Why it matters: The registered ceiling — 46,146,918 shares plus 11,780,000 warrants — is set at this first amendment and holds unchanged in the amendment that follows. The warrant leg is roughly 26% of the share leg and is a separate claim on the equity. No vote date is stated in this portion.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $40.0M · unchanged
- Outside date
- 2023-12-31 · unchanged
The clause …“Maximum Redemptions: The Business Combination Agreement includes an Available Minimum Cash Condition of $40,000,000. The minimum cash condition is determined based on the following: (i) the funds in the Trust Account, plus (ii) the”…
The clause …“BIOS or Avertix Medical if the Effective Time has not have occurred prior to December 31, 2023 (the “ Outside Date ”); provided , however , that the Business Combination Agreement may not be so terminated by or on behalf of any party”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
- What changed vs 2022-11-03trust $235.9M → $240.4M +2%deadline 2023-06-07 → 2023-12-07
trust account, combination deadline, going-concern doubt +12 moved · 2 with no prior record of ours
- Trust account
- $235.9M$240.4M
- Combination deadline
- 2023-06-072023-12-07
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 23.0M · unchanged
SpacBrain reads this as $4,488,555 was added to the trust between the two filings.
The clause …“411,773 408,461 Total Current Assets 447,144 548,763 Cash and investments held in Trust Account 240,372,461 237,775,823 TOTAL ASSETS $ 240,819,605 $ 238,324,586 LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND”…
SpacBrain reads this as 183 days later than the previous record.
The clause “2023 (the “Original Termination Date”) on a monthly basis up to six times until December 7, 2023, or for a total of up to six months after the Original Termination Date (or such earlier date as determined by the Board) (the “Extension”…
The clause …“well as the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities”…
The clause “500,000,000 shares authorized; 560,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of March 31, 2023 and December 31, 2022 56 56 Class B ordinary shares, $ 0.0001 par value; 50,000,000”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: BioPlus Acquisition Corp. ('BIOS', a Cayman Islands exempted company) filed its ORIGINAL Form S-4; the preliminary proxy statement/prospectus inside is dated May 12, 2023. It registers 42,289,441 SHARES of common stock and 11,780,000 warrants of BIOS after its domestication as a Delaware corporation, to be renamed Avertix Medical, Inc. BIOS will migrate to and domesticate as a Delaware corporation prior to the closing. Why it matters: This is the baseline of the BIOS / Avertix registration and its registered share line is 42,289,441 — a lower figure than the 46,146,918 carried in the amendments that follow, so the share count is version-specific and rose during SEC review. The warrant line of 11,780,000 is unchanged throughout. The registration statement was filed less than two weeks after the agreement was signed. No vote date is stated.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- not previously extracted$40.0M
- Outside date
- not previously extracted2023-12-31
SpacBrain reads this as the min-cash condition binds at $40,000,000.
The clause “Maximum Redemptions : The Business Combination Agreement includes an Available Minimum Cash Condition of $40,000,000. The minimum cash condition is determined based on the following: (i) the funds in the Trust Account, plus (ii) the”…
SpacBrain reads this as the agreement may be terminated from 2023-12-31.
The clause “Acquiror or the Company if the Effective Time shall not have occurred prior to December 31, 2023 (the “ Outside Date ”); provided , however , that this Agreement may not be terminated under this Section 9.01(b) by or on behalf of any”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: BioPlus Acquisition Corp. called an EGM in lieu of an annual meeting for June 2, 2023 at 11:00 a.m. Eastern at its New York offices, including a domestication under Cayman law after which it is renamed Avertix Medical, Inc. Its current deadline is June 7, 2023, which the board believes is insufficient to complete the Avertix merger disclosed on Form 8-K on May 3, 2023. The sponsor owns 5,750,000 Class B founder shares plus private placement units and has loaned it $5,000,000, repayable or convertible into units at closing. Why it matters: A $5,000,000 sponsor loan convertible into units at closing is unusually large and means the sponsor converts debt into equity ahead of public holders precisely when the vehicle needs capital. The proxy also justifies the founder conversion partly as a way to help meet Nasdaq continued listing requirements, an admission that the public float has thinned. With $241.3 million still in trust the $10.49 floor is fully funded, so redemption remains a clean cash exit ahead of a merger signed only weeks before the deadline.
outside datenothing moved · 1 with no prior record of ours
- Outside date
- not previously extracted2023-12-31
SpacBrain reads this as the agreement may be terminated from 2023-12-31.
The clause “Acquiror or the Company if the Effective Time shall not have occurred prior to December 31, 2023 (the Outside Date ); provided , however , that this Agreement may not be terminated under this Section 9.01(b) by or on behalf of any”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
- What changed vs 2022-03-11trust $234.6M → $237.8M +1%going concern APPEARED
trust account, going-concern doubt, redeemable shares +32 moved · 4 with no prior record of ours
- Trust account
- $234.6M$237.8M
- Going-concern doubt
- not statedstated
- Redeemable shares
- not previously extracted23.0M
- Combination deadline
- 2023-06-07 · unchanged
- Sponsor loans outstanding
- $300K · unchanged
- Mandate language
- we are focusing on targets in an industry where we believe o… · unchanged
SpacBrain reads this as $3,167,128 was added to the trust between the two filings.
The clause “2 of cash for operating activities. As of December 31, 2022, we had investments held in the Trust Account of $237,775,823 (including approximately $3,167,128 of interest income) consisting of U.S. Treasury Bills with a maturity of 185”…
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“for us to consummate an initial business combination; and • there is substantial doubt about our ability to continue as a “going concern”. For the complete list of risks relating to our operations, see the section titled “Risk”…
The clause “500,000,000 shares authorized; 560,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of December 31, 2022 and 2021 56 56 Class B ordinary shares, $ 0.0001 par value; 50,000,000 authorized;”…
The clause …“to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by June 7, 2023 then the Company will cease all operations except for the purpose of liquidating. The liquidity condition as well as the”…
The clause …“of our initial public offering, which occurred on December 7, 2021. The outstanding balance under the promissory note of $300,000 was repaid upon the closing of our initial public offering out of the $700,000 of offering proceeds”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
- What changed vs 2022-08-10trust $234.9M → $235.9M +0%
trust account, combination deadline, going-concern doubt +11 moved · 3 with no prior record of ours
- Trust account
- $234.9M$235.9M
- Combination deadline
- 2023-06-07 · unchanged
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 23.0M · unchanged
SpacBrain reads this as $949,499 was added to the trust between the two filings.
The clause …“Assets 628,556 1,002,286 Prepaid expenses — 369,934 Cash and investments held in Trust Account 235,883,906 234,608,695 TOTAL ASSETS $ 236,512,462 $ 235,980,915 LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND”…
The clause …“to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by June 7, 2023 then the Company will cease all operations except for the purpose of liquidating. The liquidity condition as well as the”…
The clause …“well as the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities”…
The clause “500,000,000 shares authorized; 560,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021 56 56 Class B ordinary shares, $ 0.0001 par value; 50,000,000”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.